D
Legend Biotech Corporation LEGN
$35.43 $0.732.10%
Recommendation
Sell
Prev Close
$34.70
Volume
304,619
Avg Vol (90D)
1,372,912
Market Cap
$6.37B
Dividend & Yield
--
52-Week Range
$30.17 - $69.24
P/E (TTM)
--
EPS (TTM)
-$3.82
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Is Legend Biotech Gaining or Losing Market Support?
3/5/2025 - Benzinga
Legend Biotech (LEGN, $32.98) price may climb as it broke lower Bollinger Band on Mar 03, 2025
3/4/2025 - Tickeron - Stocks
Legend Biotech Co. (NASDAQ:LEGN) Shares Bought by New York State Common Retirement Fund
3/3/2025 - MarketBeat
Legend Biotech (LEGN, $35.01) entered Downtrend as Momentum indicator drops below 0 level on Feb 28, 2025
3/1/2025 - Tickeron - Stocks
Legend Biotech (LEGN, $35.01) Stochastic Oscillator left the oversold zone on February 28, 2025
3/1/2025 - Tickeron - Stocks
Legend Biotech Co. (NASDAQ:LEGN) Receives Average Rating of "Buy" from Analysts
2/28/2025 - MarketBeat
Legend Biotech (LEGN, $36.53) Moving Average Convergence Divergence (MACD) Histogram turned negative on February 26, 2025
2/27/2025 - Tickeron - Stocks
Los Angeles Capital Management LLC Buys Shares of 172,440 Legend Biotech Co. (NASDAQ:LEGN)
2/27/2025 - MarketBeat
Legend Biotech Corp (LEGN) Announces Upcoming Conference Call for Q4 and Full-Year 2024 Results
2/25/2025 - GuruFocus
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results
2/25/2025 - GuruFocus
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results
2/25/2025 - Globe Newswire
Why Legend Biotech Corporation (LEGN) is the Most Oversold Pharma Stock to Buy According to Analysts
2/23/2025 - Insider Monkey
10 Oversold Pharma Stocks to Buy According to Analysts
2/22/2025 - Insider Monkey
Market Concerns Put Pressure on Legend Biotech Corporation (LEGN) Shares
2/21/2025 - Insider Monkey
Legend Biotech Corporation (LEGN): One of the Most Oversold Healthcare Stocks to Buy Now
2/20/2025 - Insider Monkey
Alberta Investment Management Corp Has $4.40 Million Position in Legend Biotech Co. (NASDAQ:LEGN)
2/20/2025 - MarketBeat
Legend Biotech Co. (NASDAQ:LEGN) Shares Sold by TimesSquare Capital Management LLC
2/20/2025 - MarketBeat
Legend Biotech (LEGN, $38.22) Moving Average Convergence Divergence (MACD) Histogram turned positive on February 18, 2025
2/19/2025 - Tickeron - Stocks
Peering Into Legend Biotech's Recent Short Interest
2/17/2025 - Benzinga
Empire Life Investments Inc. Acquires 38,043 Shares of Legend Biotech Co. (NASDAQ:LEGN)
2/16/2025 - MarketBeat
Is Legend Biotech (LEGN) the Best Mid-Cap Growth Stock to Buy According to Analysts?
2/13/2025 - Insider Monkey
10 Best Mid-Cap Growth Stocks to Buy According to Analysts
2/13/2025 - Insider Monkey
Mirae Asset Global Investments Co. Ltd. Sells 13,850 Shares of Legend Biotech Co. (NASDAQ:LEGN)
2/13/2025 - MarketBeat
FMR LLC Reduces Stake in Legend Biotech Corp by 26.85%
2/12/2025 - GuruFocus
Legend Biotech (LEGN, $34.63) price may climb as it broke lower Bollinger Band on Feb 11, 2025
2/12/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$520.18M
EBITDA (TTM)
-$340.56M
EBIT (TTM)
-$351.24M
Net Income (TTM)
-$348.13M
Balance Sheet
Total Assets (Q)
$1.74B
Total Debt (Q)
$346.59M
Total Liabilities (Q)
$619.72M
Book Value Per Share (Q)
$12.17
Cash Flow
Cash from Operations (TTM)
-$157.60M
Cash from Investing (TTM)
-$355.19M
Cash from Financing (TTM)
$6.96M
Net Change in Cash (TTM)
-$504.19M
Filings
Filing Date
Tuesday, November 12, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 17 and 21 (est)
Price History
Loading...
Beta
0.52
7-Day Total Return
-4.27%
30-Day Total Return
-5.37%
60-Day Total Return
-14.95%
90-Day Total Return
-19.39%
Year to Date Total Return
2.02%
1-Year Total Return
-44.45%
2-Year Total Return
-24.23%
3-Year Total Return
3.45%
5-Year Total Return
--
52-week Low
Jan 13, 2025 - $30.17
52-week High
Mar 13, 2024 - $69.24
Valuation
Market Cap
$6.37B - Mid Cap
Enterprise Value
$5.50B
Price/Sales (TTM)
6.11
Price/Book (Q)
2.85
Dividends and Shares
Shares Outstanding
91.64M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.legendbiotech.com
Phone Number
732 317 5050
Address
2101 Cottontail Lane
Somerset, NJ 08873
Country
United States
Year Founded
2014
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell... more
NASDAQ 03/06/2025 10:49AM Eastern Quotes delayed
Weiss Ratings